Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2009-01-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shiatsu Adjuvant Therapy For Schizophrenia
NCT00425399
Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients
NCT00780884
Brain Circuitry Therapeutics for Schizophrenia
NCT06341517
Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
NCT03802838
Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia
NCT05310955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We are proposing a randomized double-blind placebo-controlled trial to examine the efficacy of acupressure as adjuvant therapy added to antipsychotics in the treatment of patients with schizophrenia.
The goals of this study are twofold:
1. To assess through the highest standards of empirical research whether acupressure can benefit patients with schizophrenia.
2. To furnish data relevant to the possible physiological mechanisms by which acupressure may produce a therapeutic effect.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupressure
Acupressure adjuvant therapy
Acupressure adjuvant therapy
Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.
Placebo acupressure
Sham acupressure adjuvant therapy
Acupressure adjuvant therapy
Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.
No treatment
Wait list group (no treatment)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupressure adjuvant therapy
Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ages 18 and over
3. Clinical status stable, as reflected by changes in Brief Psychiatric Rating Scale (BPRS) (Overall \& Gorham, 1961) of less than 20% during a one month period prior to randomization, and at least one month of drug treatment without change of anti-psychotic drug or dosage.
4. Ability to cooperate with 40-minute sessions
Exclusion Criteria
2. Active bone fracture or other orthopedic problem
3. Skin condition that renders treatment unsafe or painful
4. Active infection in skin or soft tissues, such as cellulitis
5. Solid tissue malignancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herzog Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Herzog Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pesach Lichtenberg, M.D.
Role: PRINCIPAL_INVESTIGATOR
Herzog Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herzog Hospital, Department of Psychiatry
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
lichtenberg3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.